Over 500 Medtech Startup Companies Identified in Database from MedMarket Diligence, LLC

Foothill Ranch, CA, August 21, 2007 --(PR.com)-- Over 500 companies represented in the Medtech Startup Companies Database from MedMarket Diligence comprise a robust range of new technologies --- and offer many opportunities for technology licensing, joint venture, investment and acquisition. Technologies under development include medical devices, diagnostics, drugs, biomaterials and others.

Needs served by this database:
- new technology licensing, acquisition
- company acquisition
- growth market investment
- staffing services
- business-to-business (R&D, OEM, etc.)

Below is a distribution of companies by clinical/technology category (note, multiple categories possible per company):

Clinical/Technology Category (#companies)
- arrhythmia (11)
- biomaterials (37)
- biotechnology (40
- blood, organ, tissue (28
- cardiovascular diagnostics (21
- cardiovascular therapeutics (95
- critical care and patient management (3)
- dental, oral surgery (4)
- diagnostics (20)
- drug delivery (18)
- drug discovery (11)
- diagnostic imaging (27)
- interventional radiology & vascular surgery (46)
- minimally invasive therapies (55)
- neurology, neurosurgery (24)
- oncology (43)
- ophthalmology (10)
- orthopedics/musculoskeletal (72)
- patient monitoring (10)
- pharmaceutical (13)
- surgery (96)
- urogenital (16)
- wound management (26)
- other (12)

The MedMarket Diligence database of medtech startup companies is compiled and maintained through active research from multiple public domain and private sources, very often revealing companies previously kept "under the radar". The database is described, with screenshots, at http://www.mediligence.com/startups-db.htm. For additional details, contact Patrick Driscoll at 949-859-3401 or patrick-at-mediligence-dot-com.

###